Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Adam Eichas"'
Publikováno v:
mBio, Vol 1, Iss 3 (2010)
ABSTRACT Moxifloxacin is under development for expanded use against Mycobacterium tuberculosis. Rifampin is a mainstay of therapy. We examined the interaction of moxifloxacin plus rifampin for log-phase and nonreplicating persister (NRP) organisms. F
Externí odkaz:
https://doaj.org/article/346a155c92eb441da601c67a03e408da
Publikováno v:
mBio, Vol 1, Iss 3 (2010)
mBio
mBio
Moxifloxacin is under development for expanded use against Mycobacterium tuberculosis. Rifampin is a mainstay of therapy. We examined the interaction of moxifloxacin plus rifampin for log-phase and nonreplicating persister (NRP) organisms. For this e